Norwegian version of this page

PharmaTox

The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.

PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.

The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.

News

  • theaarhusteam PharmaTox at NorPEN Nov. 18, 2019 11:50 AM

    Hedvig, Sarah and Anders represented PharmaTox at the NorPEN meeting in Aarhus 14th to 15th November 2019 in Aarhus.

  • img_7241 PharmaTox at Forskningsdagene Oct. 30, 2019 2:15 PM
  • picture5 ICPE in Philadelphia! Sep. 30, 2019 5:29 AM

    Hedvig Nordeng represented PharmaSafe/PharmaTox at ICPE in Philapelphia.

  • picture4 We welcome Gabriel and Emilie Sep. 30, 2019 5:28 AM

    We welcome new PhD students Emilie Willoch Olstad and Gabriel Balaban. Below they present themselves and their background.

  • guro Master in Molecular Biosciences Sep. 25, 2019 7:13 AM

    Guro completed her master in Molecular Biosciences with a final grade of A, 24th of June 2019.

Tags: Neurotoxicology, Neuroscience, Pharmacy, Toxicology, Bioinformatics, Biostatistics, Epigenetics
Published Feb. 24, 2015 6:17 PM - Last modified Oct. 5, 2019 6:31 AM

Contact

Leader

Professor
Hedvig Nordeng
(School of Pharmacy)

Leader team

Professor
Ragnhild Paulsen 
(School of Pharmacy)

Associate Professor 
Geir Kjetil Sandve 
(Department of Informatics)

Associate Professor
Ragnhild Eskeland
(Department of Molecular Medicine)

Professor
Sven Ove Samuelsen
(Department of Mathematics)

Senior researcher
Robert Lyle
(School of Pharmacy)